The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Peritoneal carcinomatosis of gastric origin: A population‐based study on incidence, survival and risk factors
Open accessAbstract
Peritoneal carcinomatosis (PC) is an important cause of morbidity and mortality among patients with gastric cancer. The aim of the current study was to provide reliable population‐based data on the incidence, risk factors and prognosis of PC of gastric origin. All patients diagnosed with gastric cancer in the area of the Eindhoven Cancer Registry between 1995 and 2011 were included. Incidence and survival were computed and risk factors for peritoneal carcinomatosis were determined using multivariate logistic regression analysis. In total, 5,220 patients were diagnosed with gastric cancer, of whom 2,029 (39%) presented with metastatic disease. PC was present in 706 patients (14%) of whom 491 patients (9%) had PC as the only metastatic site. Younger age (<60 years), female gender, advanced T‐ and N‐stage, primary tumor of signet ring cells or linitis plastica and primary tumors covering multiple anatomical locations of the stomach were all associated with a higher odds ratios of developing PC. Median survival of patients without metastases was 14 months, but only 4 months for patients with PC. PC is a frequent condition in patients presenting with gastric cancer, especially in younger patients with advanced tumor stages. Given the detrimental influence of PC on survival, efforts should be undertaken to further explore the promising results that were obtained in preventing or treating this condition with multimodality strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of gastric cancer
Crew, K. D., & Neugut, A. I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.354 · Cited by 2,108
Chemotherapy for advanced gastric cancer
Wagner, A. D., Syn, N. L., Moehler, M., Grothe, W., Yong, W. P., Tai, B.-C., Ho, J., & Unverzagt, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004064.pub4 · Cited by 1,299
Sadeghi, B., Arvieux, C., Glehen, O., Beaujard, A. C., Rivoire, M., Baulieux, J., Fontaumard, E., Brachet, A., Caillot, J. L., Faure, J. L., et al. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o · Cited by 1,200
Chua, T. C., Moran, B. J., Sugarbaker, P. H., Levine, E. A., Glehen, O., Gilly, F. N., Baratti, D., Deraco, M., Elias, D., Sardi, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7166 · Cited by 1,071
Self-citationVerwaal, V. J., Bruin, S., Boot, H., van Slooten, G., & van Tinteren, H. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9966-2 · Cited by 1,033
Chemotherapy for advanced gastric cancer
Wagner, A. D., Unverzagt, S., Grothe, W., Kleber, G., Grothey, A., Haerting, J., & Fleig, W. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004064.pub3 · Cited by 472
Completeness of Cancer Registration in Limburg, the Netherlands
SCHOUTEN, L. J., HÖPPENER, P., VAN DEN BRANDT, P. A., KNOTTNERUS, J. A., & JAGER, J. J. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.3.369 · Cited by 375
Lemmens, V. E., Klaver, Y. L., Verwaal, V. J., Rutten, H. J., Coebergh, J. W. W., & de Hingh, I. H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25596 · Cited by 352
Self-citationYan, T. D., Black, D., Sugarbaker, P. H., Zhu, J., Yonemura, Y., Petrou, G., & Morris, D. L. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9487-4 · Cited by 343
Piessen, G., Messager, M., Leteurtre, E., Jean-Pierre, T., & Mariette, C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b21c7b · Cited by 316
Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.
Yang, D., Hendifar, A. E., Lenz, C., Togawa, K., Lenz, F., Lurje, G., Pohl, A., Winder, T. L., Ning, Y., Groshen, S. G., et al. (2011) · PubMed · doi:10.3978/j.issn.2078-6891.2010.025 · Cited by 210
Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment
Ceelen, W. P., & Bracke, M. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70335-8 · Cited by 140
Thomassen, I., Lemmens, V. E. P. P., Nienhuijs, S. W., Luyer, M. D. P., Klaver, Y. L. B., & de Hingh, I. H. J. T. (2012) · Pancreas · doi:10.1097/mpa.0b013e31825abf8c · Cited by 117
Self-citationKlaver, Y. L. B., Lemmens, V. E. P. P., Creemers, G. J., Rutten, H. J. T., Nienhuijs, S. W., & de Hingh, I. H. J. T. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq762 · Cited by 104
Self-citationPeritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities
Reingruber, B., Meyer, T., Hohenberger, W., Stremmel, C., & Knorr, C. (2004) · International Journal of Colorectal Disease · doi:10.1007/s00384-003-0524-x · Cited by 49
Cited by
Metastatic spread in patients with gastric cancer
Riihimäki, M., Hemminki, A., Sundquist, K., Sundquist, J., & Hemminki, K. (2016) · Oncotarget · doi:10.18632/oncotarget.10740 · Cited by 462
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
Alyami, M., Hübner, M., Grass, F., Bakrin, N., Villeneuve, L., Laplace, N., Passot, G., Glehen, O., & Kepenekian, V. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30318-3 · Cited by 331
Primary and metastatic peritoneal surface malignancies
Cortés-Guiral, D., Hübner, M., Alyami, M., Bhatt, A., Ceelen, W., Glehen, O., Lordick, F., Ramsay, R., Sgarbura, O., Van Der Speeten, K., et al. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00326-6 · Cited by 308
Okugawa, Y., Toiyama, Y., Hur, K., Toden, S., Saigusa, S., Tanaka, K., Inoue, Y., Mohri, Y., Kusunoki, M., Boland, C. R., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu200 · Cited by 213
Yasuda, T., Koiwa, M., Yonemura, A., Miyake, K., Kariya, R., Kubota, S., Yokomizo-Nakano, T., Yasuda-Yoshihara, N., Uchihara, T., Itoyama, R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108779 · Cited by 165
Metadata
- Authors
- Thomassen, I., van Gestel, Y. R., van Ramshorst, B., Luyer, M. D., Bosscha, K., Nienhuijs, S. W., Lemmens, V. E., & de Hingh, I. H.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2013-11-20
- Volume
- 134
- Issue
- 3
- Pages
- 622-628
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1927044883
- Cited by
- 588
- References
- 15
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.